Suppr超能文献

尼泊尔检测即治疗时代抗逆转录病毒疗法起始和维持的多层次决定因素:一项定性研究。

Multilevel determinants of antiretroviral therapy initiation and retention in the test-and-treat era of Nepal: a qualitative study.

机构信息

Department of Public Health and Community Programs, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal.

Center for Methods in Implementation and Prevention Science, Yale School of Public Health, New Haven, CT, USA.

出版信息

BMC Health Serv Res. 2024 Aug 13;24(1):927. doi: 10.1186/s12913-024-11311-6.

Abstract

BACKGROUND

The transition to the "test-and-treat" policy in Nepal in 2017, coupled with the rapid initiation of antiretroviral therapy (ART) in 2020, necessitates an in-depth understanding of factors influencing ART initiation and retention. This study investigates these factors from the perspectives of healthcare providers, families/communities, and people living with HIV (PLHIV).

METHODS

Employing a qualitative design, in-depth interviews were conducted with 24 ART clients and 26 healthcare providers across different provinces of Nepal. A comprehensive interview guide facilitated the exploration of experiences and perceptions. Interviews were transcribed verbatim, and thematic analysis was applied to distill key insights. Guided by a socio-ecological model, interviews were analyzed to identify the barriers and facilitators to ART initiation and continuation at the individual, family/community, and health system levels.

RESULTS

Facilitators and barriers were identified at three levels. Individual-level facilitators included fear of death, perceived health benefits, knowledge about HIV/ART, confidentiality, and financial support. Barriers encompassed concerns about lifelong medication, side effects, denial of HIV status, fear of disclosure, and financial constraints. At the family/community level, support from family and community health workers facilitated ART adherence, while social stigma and discrimination posed barriers. The health system's role was dual; the provision of free treatment, a client tracking system and a robust drug supply chain were facilitators, whereas logistical challenges and service accessibility during the COVID-19 pandemic were notable barriers.

CONCLUSIONS

This study highlights the various factors that influence ART initiation and retention in Nepal during the test-and-treat era. Tailored interventions should focus on increasing awareness about HIV and ART, strengthening healthcare systems, ensuring availability of medications, and providing accessible treatment during service disruptions. Furthermore, these interventions should encourage supportive environments at the individual, community, and healthcare system levels. Taking this holistic approach is essential for effectively implementing ART and achieving long-term health outcomes in light of changing public health policies.

摘要

背景

2017 年尼泊尔实施“检测即治疗”政策,加上 2020 年迅速启动抗逆转录病毒治疗(ART),这就需要深入了解影响 ART 启动和保留的因素。本研究从医疗保健提供者、家庭/社区和艾滋病毒感染者(PLHIV)的角度探讨了这些因素。

方法

采用定性设计,在尼泊尔不同省份对 24 名接受 ART 的患者和 26 名医疗保健提供者进行了深入访谈。使用全面的访谈指南探讨了经验和看法。访谈内容逐字记录下来,并采用主题分析方法提炼关键见解。根据社会生态模型,分析访谈以确定个人、家庭/社区和卫生系统各级启动和继续接受 ART 的障碍和促进因素。

结果

在三个层面上确定了促进因素和障碍。个人层面的促进因素包括对死亡的恐惧、对健康益处的认识、对 HIV/ART 的了解、保密性和经济支持。障碍包括对终身服药、副作用、对 HIV 状况的否认、对披露的恐惧和经济限制的担忧。在家庭/社区层面,来自家庭和社区卫生工作者的支持促进了 ART 的坚持,而社会耻辱和歧视则构成了障碍。卫生系统的作用是双重的;提供免费治疗、客户跟踪系统和强大的药物供应链是促进因素,而在 COVID-19 大流行期间的后勤挑战和服务可及性则是显著障碍。

结论

本研究强调了在“检测即治疗”时代影响尼泊尔 ART 启动和保留的各种因素。有针对性的干预措施应侧重于提高对 HIV 和 ART 的认识,加强卫生系统,确保药物供应,并在服务中断期间提供可及的治疗。此外,这些干预措施应鼓励在个人、社区和卫生系统各级营造支持性环境。考虑到公共卫生政策的变化,采取这种整体方法对于有效实施 ART 和实现长期健康结果至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91af/11323673/dbad61683bef/12913_2024_11311_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验